Influence of free fatty acid concentration on drug binding to plasma albumin. 1973

A A Spector, and E C Santos, and J D Ashbrook, and J E Fletcher

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009829 Oleic Acids A group of fatty acids that contain 18 carbon atoms and a double bond at the omega 9 carbon. Octadecenoic Acids,Acids, Octadecenoic,Acids, Oleic
D010169 Palmitic Acids A group of 16-carbon fatty acids that contain no double bonds. Acids, Palmitic
D011193 Potassium Iodide An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed) Antistrumin,Ioduro Potasico Rovi,Iosat,Jod beta,Jodetten Henning,Jodgamma,Jodid,Jodid Hexal,Jodid Verla,Jodid dura,Jodid-ratiopharm,Mono-Jod,Pima,SSKI,Thyro-Block,Thyroprotect,Iodide, Potassium,Jodid ratiopharm,Mono Jod,Thyro Block
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D006218 Halofenate An antihyperlipoproteinemic agent and uricosuric agent. MK-185,MK 185,MK185

Related Publications

A A Spector, and E C Santos, and J D Ashbrook, and J E Fletcher
May 1991, International journal of clinical pharmacology, therapy, and toxicology,
A A Spector, and E C Santos, and J D Ashbrook, and J E Fletcher
January 1981, Pharmacology,
A A Spector, and E C Santos, and J D Ashbrook, and J E Fletcher
May 1975, Journal of lipid research,
A A Spector, and E C Santos, and J D Ashbrook, and J E Fletcher
January 1989, Czechoslovak medicine,
A A Spector, and E C Santos, and J D Ashbrook, and J E Fletcher
January 1994, Biochemical pharmacology,
A A Spector, and E C Santos, and J D Ashbrook, and J E Fletcher
November 1972, The Journal of biological chemistry,
A A Spector, and E C Santos, and J D Ashbrook, and J E Fletcher
March 2022, Physiological reports,
A A Spector, and E C Santos, and J D Ashbrook, and J E Fletcher
April 1990, European journal of biochemistry,
A A Spector, and E C Santos, and J D Ashbrook, and J E Fletcher
April 2021, Journal of the Formosan Medical Association = Taiwan yi zhi,
Copied contents to your clipboard!